Specialchem: April 2008
Ciba will increase prices across its pigment and additive product ranges for coatings applications. Price increases of 5%-20% will be applied immediately or as contracts allow.
Siegfried Winkelbeiner, Global Head of Business Line Coatings at Ciba, explains: "In addition to our ongoing efforts to improve efficiency across operations, price increases are necessary to support continued investment in capacity and innovation in our coatings business and to help absorb the significant increases in raw material, energy and transport costs. We will work with our customers to mitigate the impact as much as possible."


Company Press Release: April 2008
Dow Biocides announces the cancellation of ALL off-list prices for all glutaraldehyde products and grades, effective April 1, 2008, or as contracts allow.
“Globally, glutaraldehyde remains in short supply while growth rates remain at record levels. Costs continue to escalate in this highly regulated industry leading to continued upward cost pressures in the market. These increased pressures make it imperative that the product is at reinvestment levels in order to continue to grow with market demand,” said Nanette Hermsen, global marketing manager for Dow Biocides.
Glutaraldehyde from Dow Biocides is sold under a number of tradenames including: UCARCIDE™, UCARSAN™, AQUCAR™, GLUTEX™ and as industrial use product named Glutaraldehyde 25% and 50%.  Dow also offers the glutaraldehyde products under at least 100 sub-registrations as customer-branded products.


Company press release: March 2008
Troy Corporation will increase prices for select industrial biocides. The increases will be implemented on all off-list prices and will be effective on April 15, 2008, or as contracts allow. The price increases are effective for Polyphase® and Troysan® dry film preservatives and Mergal® bactericides
The new prices will be effective for all shipments made after April 15, 2008. Global increases in the cost of raw materials, energy, transportation and regulatory support required to supply these products and services to our customers have made these increases necessary.


Company press release: January 2008
Agion Technologies announced the company has secured additional regulatory approvals for specific formulations from government agencies in the U.S. and Switzerland.
The Environmental Protection Agency (EPA) has granted approval for the Agion formulation for use in medical devices, equipment, and supplies. This clears the path for the Agion antimicrobial technology to be incorporated directly into various materials including plastics, fibers, coatings, films, and laminates for use in the healthcare industry. The EPA registration for this market will enable additional manufacturers to incorporate Agion’s antimicrobial technology into their end products. Agion, Nature’s Antimicrobial, has recently been published to the International Cosmetic Ingredient Dictionary and Handbook as maintained by the Personal Care Products Council (PCPC), clearing the way for the expansion of Agion technology for use in consumer cosmetic, toiletry, and fragrance applications in the United States, Europe and Asia.
Agion has also received two additional National Sanitation Foundation (NSF) Standard 51 certifications for food processing and food service equipment materials. Agion’s partners hold NSF Standard 42 certifications, and Agion maintains EPA, FDA, (Food & Drug Administration), and USDA approvals for different formulations for use in food and water touch applications.
Additionally, Agion has announced that approval has been obtained for indirect food contact by the European Food Safety Authority (EFSA). This approval opens the door for further development in Europe of Agion-protected antimicrobial products for food packaging, preparation, and storage. Already a well known brand in the food industry in the United States, Agion continues to expand with additional regulatory approvals worldwide.

Agion, a global leader in antimicrobial solutions, continues to maintain regulatory approvals for different formulations from the EPA, FDA, EFSA, and NSF and is notified under the European BPD (Biocidal Products Directive) in addition to various other approvals and recognition in Europe, Asia, Canada, and Latin America.


PRNewswire: March 2008
The U.S. Environmental Protection Agency (EPA) has approved the registration of antimicrobial copper alloys, with public health claims. These public health claims acknowledge that copper, brass and bronze are capable of killing harmful, potentially deadly bacteria. Copper is the first solid surface material to receive this type of EPA registration, which is supported by extensive antimicrobial efficacy testing.
The EPA registration is based on independent laboratory testing using EPA-prescribed protocols that demonstrate the metals' ability to kill specific disease-causing bacteria, including Methicillin-resistant Staphylococcus aureus (MRSA). MRSA is one of the most virulent strains of antibiotic-resistant bacteria and a common cause of hospital- and community-acquired infections.
Testing under EPA-approved protocols demonstrates that copper, brasses and bronzes are effective against a number of disease-causing bacteria. For example, one study shows that on copper alloy surfaces, greater than 99.9% of MRSA "superbugs" are killed within two hours at room temperature.
The following statements are included in the registration: "When cleaned regularly, antimicrobial copper alloys surfaces kill greater than 99.9% of (specific) bacteria within two hours, and continue to kill more than 99% of (these) bacteria even after repeated contamination," and, "The use of a copper alloy surface is a supplement to and not a substitute for standard infection control practices; users must continue to follow all current infection control practices, including those practices related to cleaning and disinfection of environmental surfaces. The copper alloy surface material has been shown to reduce microbial contamination, but it does not necessarily prevent cross contamination."